Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

Fig. 2

a Activity of MP1 alone in highly MYCN amplified NB cell line BE-2c. Treatments were for 18 h at concentrations of MP1 of 0.1 μM, 0.25 μM, 0.5 μM, 1.0 μM, 5.0 μM, 10.0 μM, and 50 μM b MP1 plus TEM at MP1 concentrations of 0.025 μM, 0.050 μM, 0.1 μM, 0.25 μM, and 0.5 μM plus 1.0 μM. Reported as means of 8 data points ± SD

Back to article page
\